J&J Ordered to Pay $40 Million in Talc Trial

J&J Ordered to Pay $40 Million in Bellwether Talc Trial in Los Angeles

Highlights

• Los Angeles jury awards $40 million in talc cancer case

• Two women link ovarian cancer to Johnson & Johnson baby powder

• First bellwether trial in coordinated California litigation

• J&J plans to appeal the multi-million dollar verdict

• Verdict could impact thousands of similar pending claims

The Core Facts

A jury in Los Angeles has delivered a $40 million verdict against Johnson & Johnson in the first bellwether trial in California involving allegations that the company’s talcum powder caused ovarian cancer. The jury found in favor of two women, Monica Kent and Deborah Schultz, who claimed they developed cancer after decades of using the company’s talc-based baby powder products.

The award included $18 million for Kent and $22 million for Schultz and her husband. Jurors concluded that Johnson & Johnson failed to adequately warn consumers about the cancer risks allegedly associated with its products. The plaintiffs asserted that their daily use of baby powder over several years was a contributing factor in their ovarian cancer diagnoses.

Johnson & Johnson maintains that its products are safe, do not contain asbestos, and are supported by decades of scientific research. The company announced that it would appeal the verdict.

Background on Individuals and Trial

Monica Kent and Deborah Schultz are both California residents who testified that they used Johnson & Johnson’s talc-based powders for over 30 years. Both were later diagnosed with ovarian cancer and underwent extensive treatment. Their lawsuit alleged that the company had long been aware of the potential risks linked to talc but chose not to warn the public.

The trial, which took place in Los Angeles Superior Court, lasted four weeks. It involved extensive testimony from medical experts, toxicologists, and corporate witnesses. The plaintiffs’ attorneys introduced internal company documents to argue that Johnson & Johnson knew about the presence of asbestos in some of its talc mines and products but chose not to disclose the risk.

The jury deliberated for less than a full day before returning the multimillion-dollar verdict in favor of the plaintiffs.

Political and Institutional Context

The case arrives at a time when Johnson & Johnson faces tens of thousands of similar lawsuits across the United States. In prior years, the company attempted to use a controversial bankruptcy maneuver by spinning off its talc liabilities into a separate entity and declaring that entity bankrupt to pause litigation. That strategy was rejected by federal courts, forcing the company to resume fighting cases in court.

The legal battles have political and institutional implications. Critics of the bankruptcy strategy, including lawmakers and consumer advocates, argue it was a misuse of bankruptcy protections meant to shield the company from accountability. The reactivation of individual trials like this one marks a return to standard litigation and potentially opens the door to many more jury awards.

Legal Context and Precedent

This trial is considered a bellwether in the California Judicial Council Coordinated Proceedings, where multiple talc-related claims have been grouped for efficiency. Bellwether trials help both sides assess how future juries might view similar evidence and often set the tone for mass tort litigation.

Juries in other states have previously awarded large sums to talc plaintiffs. In one high-profile Missouri case in 2018, a jury awarded $4.7 billion to 22 women. That judgment was later reduced but partially upheld on appeal. Johnson & Johnson has repeatedly insisted that scientific studies do not support the claim that its talcum powder causes cancer and that its products have consistently met regulatory standards.

The plaintiffs in the Los Angeles case brought claims including failure to warn, negligence, and defective product liability under California law.

Implications

This $40 million verdict carries substantial implications for the broader talc litigation landscape. With more than 67,000 cases still pending nationwide, trial outcomes like this one could influence the pace of settlements, increase financial exposure for Johnson & Johnson, and shape how judges and juries handle similar claims.

The verdict also reflects jurors’ willingness to accept that daily consumer use of talc products, especially by women over long periods, can be credibly linked to serious health consequences. Attorneys for the plaintiffs said the decision was a major step forward in holding large corporations accountable for product safety.

For Johnson & Johnson, the verdict poses both reputational and financial risks. Despite moving away from talc-based powders and transitioning to cornstarch-based alternatives, the company remains tied to legacy products and their legal aftermath.

What’s Next

Johnson & Johnson has vowed to appeal the Los Angeles verdict, likely challenging the sufficiency of the evidence and alleging errors in the trial process. Appeals could delay final resolution for months or years.

Meanwhile, additional bellwether trials are scheduled in California and other states. These cases will continue to test the strength of the evidence presented by plaintiffs and whether jurors view the company’s past conduct as negligent or deceptive.

The broader litigation could ultimately prompt global settlement talks, especially if further verdicts continue to favor plaintiffs. Any such settlement would likely require billions in payouts and court approval.

Conclusion

The $40 million award against Johnson & Johnson in Los Angeles underscores the growing legal pressure the company faces in its ongoing talc litigation. As one of the first bellwether trials in California, this case will serve as a roadmap for how future juries might respond to similar allegations. The stakes are high, not just for the company and claimants, but for the broader principles of corporate accountability, consumer safety, and judicial resolution of mass torts. Whether through continued litigation or potential settlements, the talc controversy is far from over.